137 related articles for article (PubMed ID: 31949778)
21. Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates.
Hamze M; Ismail MB; Rahmo AK; Dabboussi F
Int J Mycobacteriol; 2015 Sep; 4(3):228-32. PubMed ID: 27649870
[TBL] [Abstract][Full Text] [Related]
22. [Comprehensive identification of compensatory mutations in rifampicin-resistant
Zuo TY; Liu QY; Gan MY; Gao Q
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Mar; 41(3):207-212. PubMed ID: 29518850
[No Abstract] [Full Text] [Related]
23. Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families.
Kasule GW; Kateete DP; Joloba ML
BMC Infect Dis; 2016 Apr; 16():173. PubMed ID: 27097724
[TBL] [Abstract][Full Text] [Related]
24. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes.
Espasa M; González-Martín J; Alcaide F; Aragón LM; Lonca J; Manterola JM; Salvadó M; Tudó G; Orús P; Coll P
J Antimicrob Chemother; 2005 Jun; 55(6):860-5. PubMed ID: 15879493
[TBL] [Abstract][Full Text] [Related]
25. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Nimri L; Samara H; Batchoun R
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
[TBL] [Abstract][Full Text] [Related]
26. Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
J Antimicrob Chemother; 2015 Dec; 70(12):3214-21. PubMed ID: 26311839
[TBL] [Abstract][Full Text] [Related]
27. [DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico].
Bolado-Martínez E; Pérez-Mendoza A; Alegría-Morquecho FM; Candia-Plata Mdel C; Aguayo-Verdugo Mdel R; Alvarez-Hernández G
Salud Publica Mex; 2012; 54(2):167-70. PubMed ID: 22535176
[TBL] [Abstract][Full Text] [Related]
28. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
29. Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine.
Nikolayevskyy VV; Brown TJ; Bazhora YI; Asmolov AA; Balabanova YM; Drobniewski FA
Clin Microbiol Infect; 2007 Feb; 13(2):129-138. PubMed ID: 17328724
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of mutation associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates.
Negi SS; Anand R; Pasha ST; Gupta S; Basir SF; Khare S; Lal S
Indian J Exp Biol; 2006 Jul; 44(7):547-53. PubMed ID: 16872043
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.
Bolotin S; Alexander DC; Chedore P; Drews SJ; Jamieson F
J Antimicrob Chemother; 2009 Aug; 64(2):263-6. PubMed ID: 19520719
[TBL] [Abstract][Full Text] [Related]
32. Genetic diversity of Mycobacterium tuberculosis and transmission associated with first-line drug resistance: a first analysis in Jalisco, Mexico.
Lopez-Avalos G; Gonzalez-Palomar G; Lopez-Rodriguez M; Vazquez-Chacon CA; Mora-Aguilera G; Gonzalez-Barrios JA; Villanueva-Arias JC; Sandoval-Diaz M; Miranda-Hernández U; Alvarez-Maya I
J Glob Antimicrob Resist; 2017 Dec; 11():90-97. PubMed ID: 28760681
[TBL] [Abstract][Full Text] [Related]
33. Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana.
Homolka S; Meyer CG; Hillemann D; Owusu-Dabo E; Adjei O; Horstmann RD; Browne EN; Chinbuah A; Osei I; Gyapong J; Kubica T; Ruesch-Gerdes S; Niemann S
Int J Med Microbiol; 2010 Nov; 300(7):489-95. PubMed ID: 20538518
[TBL] [Abstract][Full Text] [Related]
34. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
[TBL] [Abstract][Full Text] [Related]
35. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
Isakova ZhT
Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
Yu XL; Wen ZL; Chen GZ; Li R; Ding BB; Yao YF; Li Y; Wu H; Guo XK; Wang HH; Zhang SL
J Antibiot (Tokyo); 2014 Apr; 67(4):291-7. PubMed ID: 24326341
[TBL] [Abstract][Full Text] [Related]
37. Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.
Malinga L; Brand J; Jansen van Rensburg C; Cassell G; van der Walt M
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S36-S37. PubMed ID: 28043598
[TBL] [Abstract][Full Text] [Related]
38. Whole genome sequencing data of 1110 Mycobacterium tuberculosis isolates identifies insertions and deletions associated with drug resistance.
Zeng X; Kwok JS; Yang KY; Leung KS; Shi M; Yang Z; Yam WC; Tsui SK
BMC Genomics; 2018 May; 19(1):365. PubMed ID: 29769016
[TBL] [Abstract][Full Text] [Related]
39. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis.
Srivastava K; Das R; Jakhmola P; Gupta P; Chauhan DS; Sharma VD; Singh HB; Sachan AS; Katoch VM
Indian J Med Res; 2004 Aug; 120(2):100-5. PubMed ID: 15347859
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of novel
Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
